InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Hearne Michael S, Chief Financial Officer. Insider active across 1 company, notably La Jolla Pharmaceutical Co. Aggregated, 28 filings have been published. History available since 30 April 2021. The latest transaction was disclosed on 22 August 2022 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hearne Michael S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
10,186 shares@ US$6.2363.5% of flowCommon StockSEC:0000899243-22-029649:0
236 shares@ US$2.71150.6% of flowCommon StockSEC:0001209191-22-040873:0
236 shares@ US$2.721.7% of flowCommon StockSEC:0001209191-22-037956:0
189 shares@ US$3.40851.7% of flowCommon StockSEC:0001209191-22-033597:0
188 shares@ US$3.40851.7% of flowCommon StockSEC:0001209191-22-029751:0
185 shares@ US$3.4681.7% of flowCommon StockSEC:0001209191-22-026783:0
173 shares@ US$3.71451.6% of flowCommon StockSEC:0001209191-22-024634:0
177 shares@ US$3.62951.6% of flowCommon StockSEC:0001209191-22-022587:0
190 shares@ US$3.3661.6% of flowCommon StockSEC:0001209191-22-019899:0
185 shares@ US$3.47651.6% of flowCommon StockSEC:0001209191-22-014875:0
169 shares@ US$3.7911.6% of flowCommon StockSEC:0001209191-22-010852:0
1,675 shares@ US$3.935516.4% of flowCommon StockSEC:0001209191-22-006559:0
148 shares@ US$4.1821.5% of flowCommon StockSEC:0001209191-22-003889:0
157 shares@ US$3.91851.5% of flowCommon StockSEC:0001209191-22-000956:0
173 shares@ US$3.57850.6% of flowCommon StockSEC:0001209191-21-070378:0
186 shares@ US$3.3150.6% of flowCommon StockSEC:0001209191-21-067643:0
181 shares@ US$3.40850.6% of flowCommon StockSEC:0001209191-21-065155:0
181 shares@ US$3.4170.6% of flowCommon StockSEC:0001209191-21-062451:0
183 shares@ US$3.3660.6% of flowCommon StockSEC:0001209191-21-060947:0
182 shares@ US$3.39150.6% of flowCommon StockSEC:0001209191-21-059054:0
546 shares@ US$3.39151.8% of flowCommon StockSEC:0001209191-21-056669:0
201 shares@ US$3.06850.6% of flowCommon StockSEC:0001209191-21-049386:0
193 shares@ US$3.1960.6% of flowCommon StockSEC:0001209191-21-047252:0
170 shares@ US$3.6380.6% of flowCommon StockSEC:0001209191-21-045200:0
148 shares@ US$4.1650.6% of flowCommon StockSEC:0001209191-21-041585:0
25 of 28 declarations
About Hearne Michael S
Hearne Michael S is Chief Financial Officer at La Jolla Pharmaceutical Co. He has 28 filings, and across the 28 sampled filings from 2021-05-04 to 2022-08-24, the amounts shown are EUR 0 in buys and EUR 63845 in sells, with the modal transaction nature listed as Attribution.
